Low Seroprevalence among Undetected COVID-19 Cases, Faroe Islands, November 2020

• DOI: 10.3201/eid2801.210917
• Publication Date: 2021-11-10T14:29:14Z
• Authors: Maria Skaalum Pet...; Marin Strøm; Jógvan Páll Fjall...; Jóhanna Ljósá Hansen; Sólrun Larsen; Eina H. Eliasen; Malan Johansen; Anna Sofía Veyhe; Marnar Fríðheim K...; Pál Weihe
• Keywords: SARS; SARS-CoV-2; Denmark; R; COVID-19; Infectious and parasitic diseases; RC109-216; Antibodies, Viral; 3. Good health; respiratory infections; 03 medical and health sciences; 0302 clinical medicine; coronavirus disease; Seroepidemiologic Studies; Research Letter; Prevalence; Medicine; Humans; severe acute respiratory syndrome coronavirus 2

We conducted a second nationwide severe acute respiratory syndrome coronavirus 2 seroprevalence study in the Faroe Islands during November 2020. We found crude seroprevalence was 0.3% and prevalence was 0.4% after adjusting for test sensitivity and specificity. This low seroprevalence supports the prevention strategies used in the Faroe Islands.